Skip to main content

Advertisement

SpringerLink
Log in

Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients

  • Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Familial Mediterranean fever is a hereditary disease, characterized by recurrent episodes of inflammation. Colchicine, the mainstay of therapy, is administered continuously to all diagnosed FMF patients. Drug–drug interaction between colchicine and clarithromycin, resulting in colchicine intoxication, has been noted, mainly in association with gout and pneumonia. In FMF, this adverse event has been scarcely described. We present and characterize six patients with clarithromycin-related colchicine intoxication, aiming mainly at characterizing the FMF-specific features of this event. This study is a retrospective analysis, based on clinical and hospital records of all FMF patients admitted to one hospital during 2002–2015, for colchicine intoxication, precipitated by consumption of clarithromycin. All six patients were women who received colchicine for FMF, and clarithromycin for Helicobacter pylori (HBP) gastric infection. Their daily dosages of colchicine ranged from 1.5 to 2.5 mg. Two had mild FMF, two moderate and two severe diseases. Colchicine intoxication occurred despite intact kidney function and was characterized by abdominal pain, diarrhea, weakness, rhabdomyolysis, hepatitis, kidney impairment and bone marrow injury. It is concluded that clarithromycin-induced colchicine intoxication is a hazard in FMF. It occurs despite normal kidney function and standard colchicine dose and is associated with female sex and moderate to severe FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Almeida de Jesus A, Goldbach-Mansky R (2013) Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol 147:155–174

    Article  CAS  PubMed  Google Scholar 

  2. Touitou I, Koné-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829

    Article  CAS  PubMed  Google Scholar 

  3. Yang J, Xu H, Shao F (2014) Immunological function of familial Mediterranean fever disease protein pyrin. Sci China Life Sci 57:1156–1161

    Article  CAS  PubMed  Google Scholar 

  4. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651

    Article  CAS  PubMed  Google Scholar 

  5. Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411–419

    Article  CAS  PubMed  Google Scholar 

  6. Terkeltaub RA, Furst DE, Digiacinto JL, Kook KA, Davis MW (2011) Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors. Arthritis Rheum 63:2226–2237

    Article  CAS  PubMed  Google Scholar 

  7. Declèves X, Chappey O, Boval B, Niel E, Scherrmann JM (1998) P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells. Pharm Res 15:712–718

    Article  PubMed  Google Scholar 

  8. Cisternino S, Rousselle C, Debray M, Scherrmann JM (2004) In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug–drug interactions at the mouse blood–brain barrier. Pharm Res 21:1382–1389

    Article  CAS  PubMed  Google Scholar 

  9. Food and Drug Administration (2009) Information for healthcare professionals: new safety information for colchicine (marketed as colcrys). http://www.fda.gov/Drugs/DrugSafety/ Accessed 2009

  10. Dogukan A, Oymak FS, Taskapan H, Güven M, Tokgoz B, Utas C (2001) Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration. Clin Nephrol 55:181–182

    CAS  PubMed  Google Scholar 

  11. Akdag I, Ersoy A, Kahvecioglu S, Gullulu M, Dilek K (2006) Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure. J Nephrol 19:515–517

    CAS  PubMed  Google Scholar 

  12. Mor A, Shinar Y, Zaks N, Langevitz P, Chetrit A, Shtrasburg S, Rabinovitz E, Livneh A (2005) Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 35:57–64

    Article  PubMed  Google Scholar 

  13. Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh A (2004) Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 33:273–282

    Article  CAS  PubMed  Google Scholar 

  14. Rollot F, Pajot O, Chauvelot-Moachon L, Nazal EM, Kélaïdi C, Blanche P (2004) Acute colchicine intoxication during clarithromycin administration. Ann Pharmacother 38:2074–2077

    Article  PubMed  Google Scholar 

  15. Cheng VC, Ho PL, Yuen KY (2005) Two probable cases of serious drug interaction between clarithromycin and colchicine. South Med J 98:811–813

    Article  PubMed  Google Scholar 

  16. van der Velden W, Huussen J, Ter Laak H, de Sévaux R (2008) Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. Neth J Med 66:204–206

    PubMed  Google Scholar 

  17. McKinnell J, Tayek JA (2009) Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. J Clin Rheumatol 15:303–305

    Article  PubMed  Google Scholar 

  18. Kim JB, Kim S, Yoon SY, Lee T, Lee YS, Kwon HS, Cho YS, Moon HB, Kim YG, Kim TB (2012) Colchicine-induced rhabdomyolysis caused by interaction with clarithromycin in a patient with Behçet disease. J Clin Rheumatol 18:453–454

    Article  PubMed  Google Scholar 

  19. Çelebi ZK, Akturk S, Oktay EI, Duman N, Keven K (2013) Colchicine-induced rhabdomyolysis following a concomitant use of clarithromycin in a haemodialysis patient with familial Mediterranean fever. Clin Kidney J 6:665–666

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cohen O, Locketz G, Hershko AY, Gorshtein A, Levy Y (2015) Colchicine-clarithromycin-induced rhabdomyolysis in familial Mediterranean fever patients under treatment for Helicobacter pylori. Rheumatol Int 35:1937–1941

    Article  PubMed  Google Scholar 

  21. Hung IF, Wu AK, Cheng VC, Tang BS, To KW, Yeung CK, Woo PC, Lau SK, Cheung BM, Yuen KY (2005) Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 41:291–300

    Article  CAS  PubMed  Google Scholar 

  22. Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562–1568

    Article  CAS  PubMed  Google Scholar 

  23. La Regina M, Ben-Chetrit E, Gasparyan AY, Livneh A, Ozdogan H, Manna R (2013) Current trends in colchicine treatment in familial Mediterranean fever. Clin Exp Rheumatol 31(Suppl 77):41–46

    PubMed  Google Scholar 

  24. Giancane G, Ter Haar NM, Wulffraat N, Vastert SJ, Barron K, Hentgen et al (2015) Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis 74:635–641

    Article  CAS  PubMed  Google Scholar 

  25. Eusebi LH, Zagari RM, Bazzoli F (2014) Epidemiology of Helicobacter pylori infection. Helicobacter 19(Suppl 1):1–5

    Article  PubMed  Google Scholar 

  26. Levsky ME, Miller MA, Masneri DA, Borys D (2008) Colchicine exposures: the Texas experience. South Med J 101:480–483

    Article  PubMed  Google Scholar 

  27. Evans TI, Wheeler MT, Small RE, Breitbach SA, Sanders KM, Roberts WN (1996) A comprehensive investigation of inpatient intravenous colchicine use shows more education is needed. J Rheumatol 23:143–148

    CAS  PubMed  Google Scholar 

  28. Kesselheim AS, Franklin JM, Kim SC, Seeger JD, Solomon DH (2015) Reductions in use of colchicine after FDA enforcement of market exclusivity in a commercially insured population. J Gen Intern Med 30:1633–1638

    Article  PubMed  PubMed Central  Google Scholar 

  29. Nishizawa T, Suzuki H, Hibi T (2009) Quinolone-based third-line therapy for Helicobacter pylori eradication. J Clin Biochem Nutr 44:119–124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Berning M, Krasz S, Miehlke S (2011) Should quinolones come first in Helicobacter pylori therapy? Therap Adv Gastroenterol 4:103–114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y (2010) Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) 48:407–414

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine F, Sheba Medical Center, Tel Hashomer, 5265601, Ramat Gan, Israel

    Soad Haj Yahia, Ilan Ben Zvi & Avi Livneh

  2. Heller Institute of Medical Research, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

    Ilan Ben Zvi & Avi Livneh

  3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Ilan Ben Zvi & Avi Livneh

Authors
  1. Soad Haj Yahia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilan Ben Zvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avi Livneh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Avi Livneh.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haj Yahia, S., Ben Zvi, I. & Livneh, A. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. Rheumatol Int 38, 141–147 (2018). https://doi.org/10.1007/s00296-017-3823-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3823-1

Keywords

Search

Navigation